EGFR and non-small cell lung carcinoma: In this study, we systematically evaluated the ability of circulating lncRNAs as potential markers for predicting EGFR mutation status, EGFR‐TKI efficacy, and monitoring the efficacy of EGFR‐TKI in patients with EGFR‐positive NSCLC.